Logo image of TMO

THERMO FISHER SCIENTIFIC INC (TMO) Stock Fundamental Analysis

NYSE:TMO - New York Stock Exchange, Inc. - US8835561023 - Common Stock - Currency: USD

429.33  +1.57 (+0.37%)

After market: 429.33 0 (0%)

Fundamental Rating

5

Taking everything into account, TMO scores 5 out of 10 in our fundamental rating. TMO was compared to 55 industry peers in the Life Sciences Tools & Services industry. While TMO belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. TMO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year TMO was profitable.
TMO had a positive operating cash flow in the past year.
In the past 5 years TMO has always been profitable.
Each year in the past 5 years TMO had a positive operating cash flow.
TMO Yearly Net Income VS EBIT VS OCF VS FCFTMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

TMO has a better Return On Assets (6.58%) than 87.27% of its industry peers.
TMO has a better Return On Equity (13.19%) than 87.27% of its industry peers.
TMO has a Return On Invested Capital of 7.21%. This is in the better half of the industry: TMO outperforms 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for TMO is significantly below the industry average of 13.60%.
Industry RankSector Rank
ROA 6.58%
ROE 13.19%
ROIC 7.21%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)7.48%
ROIC(5y)8.55%
TMO Yearly ROA, ROE, ROICTMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

TMO's Profit Margin of 15.19% is amongst the best of the industry. TMO outperforms 89.09% of its industry peers.
TMO's Profit Margin has been stable in the last couple of years.
The Operating Margin of TMO (18.27%) is better than 83.64% of its industry peers.
TMO's Operating Margin has improved in the last couple of years.
TMO has a Gross Margin of 41.34%. This is comparable to the rest of the industry: TMO outperforms 43.64% of its industry peers.
TMO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.27%
PM (TTM) 15.19%
GM 41.34%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
TMO Yearly Profit, Operating, Gross MarginsTMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TMO is destroying value.
TMO has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, TMO has less shares outstanding
TMO has a better debt/assets ratio than last year.
TMO Yearly Shares OutstandingTMO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
TMO Yearly Total Debt VS Total AssetsTMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

An Altman-Z score of 3.55 indicates that TMO is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.55, TMO is doing good in the industry, outperforming 70.91% of the companies in the same industry.
TMO has a debt to FCF ratio of 5.08. This is a neutral value as TMO would need 5.08 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.08, TMO is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
A Debt/Equity ratio of 0.64 indicates that TMO is somewhat dependend on debt financing.
TMO has a Debt to Equity ratio of 0.64. This is in the lower half of the industry: TMO underperforms 69.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 5.08
Altman-Z 3.55
ROIC/WACC0.7
WACC10.26%
TMO Yearly LT Debt VS Equity VS FCFTMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

TMO has a Current Ratio of 1.77. This is a normal value and indicates that TMO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.77, TMO is doing worse than 65.45% of the companies in the same industry.
TMO has a Quick Ratio of 1.38. This is a normal value and indicates that TMO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.38, TMO is doing worse than 63.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.38
TMO Yearly Current Assets VS Current LiabilitesTMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.30% over the past year.
Measured over the past years, TMO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.12% on average per year.
TMO shows a small growth in Revenue. In the last year, the Revenue has grown by 0.96%.
TMO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.92% yearly.
EPS 1Y (TTM)1.3%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%0.78%
Revenue 1Y (TTM)0.96%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%0.18%

3.2 Future

The Earnings Per Share is expected to grow by 8.79% on average over the next years. This is quite good.
Based on estimates for the next years, TMO will show a small growth in Revenue. The Revenue will grow by 4.89% on average per year.
EPS Next Y3.15%
EPS Next 2Y6.79%
EPS Next 3Y8.38%
EPS Next 5Y8.79%
Revenue Next Year2.15%
Revenue Next 2Y4.1%
Revenue Next 3Y5.02%
Revenue Next 5Y4.89%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TMO Yearly Revenue VS EstimatesTMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
TMO Yearly EPS VS EstimatesTMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.60, which indicates a rather expensive current valuation of TMO.
Based on the Price/Earnings ratio, TMO is valued cheaper than 83.64% of the companies in the same industry.
When comparing the Price/Earnings ratio of TMO to the average of the S&P500 Index (27.45), we can say TMO is valued slightly cheaper.
With a Price/Forward Earnings ratio of 17.22, TMO is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TMO indicates a rather cheap valuation: TMO is cheaper than 85.45% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, TMO is valued a bit cheaper.
Industry RankSector Rank
PE 19.6
Fwd PE 17.22
TMO Price Earnings VS Forward Price EarningsTMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

TMO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. TMO is cheaper than 80.00% of the companies in the same industry.
78.18% of the companies in the same industry are more expensive than TMO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.1
EV/EBITDA 17.43
TMO Per share dataTMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TMO does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of TMO may justify a higher PE ratio.
PEG (NY)6.23
PEG (5Y)1.62
EPS Next 2Y6.79%
EPS Next 3Y8.38%

6

5. Dividend

5.1 Amount

TMO has a yearly dividend return of 0.40%, which is pretty low.
TMO's Dividend Yield is rather good when compared to the industry average which is at 0.51. TMO pays more dividend than 89.09% of the companies in the same industry.
With a Dividend Yield of 0.40, TMO pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 0.4%

5.2 History

The dividend of TMO is nicely growing with an annual growth rate of 15.37%!
TMO has paid a dividend for at least 10 years, which is a reliable track record.
TMO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)15.37%
Div Incr Years7
Div Non Decr Years12
TMO Yearly Dividends per shareTMO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

TMO pays out 9.16% of its income as dividend. This is a sustainable payout ratio.
TMO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.16%
EPS Next 2Y6.79%
EPS Next 3Y8.38%
TMO Yearly Income VS Free CF VS DividendTMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
TMO Dividend Payout.TMO Dividend Payout, showing the Payout Ratio.TMO Dividend Payout.PayoutRetained Earnings

THERMO FISHER SCIENTIFIC INC

NYSE:TMO (7/3/2025, 8:13:12 PM)

After market: 429.33 0 (0%)

429.33

+1.57 (+0.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)04-23 2025-04-23/bmo
Earnings (Next)07-23 2025-07-23/bmo
Inst Owners92.22%
Inst Owner Change0.08%
Ins Owners0.1%
Ins Owner Change4.43%
Market Cap162.07B
Analysts81.14
Price Target567.31 (32.14%)
Short Float %1.3%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 0.4%
Yearly Dividend1.52
Dividend Growth(5Y)15.37%
DP9.16%
Div Incr Years7
Div Non Decr Years12
Ex-Date06-13 2025-06-13 (0.43)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.81%
Min EPS beat(2)-0.07%
Max EPS beat(2)1.69%
EPS beat(4)2
Avg EPS beat(4)1.26%
Min EPS beat(4)-0.34%
Max EPS beat(4)3.75%
EPS beat(8)4
Avg EPS beat(8)0.79%
EPS beat(12)7
Avg EPS beat(12)1.85%
EPS beat(16)11
Avg EPS beat(16)5.33%
Revenue beat(2)2
Avg Revenue beat(2)0.16%
Min Revenue beat(2)0.04%
Max Revenue beat(2)0.28%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)0.28%
Revenue beat(8)4
Avg Revenue beat(8)-0.68%
Revenue beat(12)7
Avg Revenue beat(12)1.53%
Revenue beat(16)11
Avg Revenue beat(16)3.62%
PT rev (1m)-1.97%
PT rev (3m)-15.77%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)-6.53%
EPS NY rev (1m)0.06%
EPS NY rev (3m)-4.33%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-0.9%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 19.6
Fwd PE 17.22
P/S 3.78
P/FCF 24.1
P/OCF 19.91
P/B 3.28
P/tB N/A
EV/EBITDA 17.43
EPS(TTM)21.9
EY5.1%
EPS(NY)24.93
Fwd EY5.81%
FCF(TTM)17.82
FCFY4.15%
OCF(TTM)21.56
OCFY5.02%
SpS113.64
BVpS130.84
TBVpS-32.92
PEG (NY)6.23
PEG (5Y)1.62
Profitability
Industry RankSector Rank
ROA 6.58%
ROE 13.19%
ROCE 9.13%
ROIC 7.21%
ROICexc 7.75%
ROICexgc 34.2%
OM 18.27%
PM (TTM) 15.19%
GM 41.34%
FCFM 15.68%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)7.48%
ROIC(5y)8.55%
ROICexc(3y)8.22%
ROICexc(5y)9.55%
ROICexgc(3y)40.87%
ROICexgc(5y)46.64%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexcg growth 3Y-8.22%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
F-Score8
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 5.08
Debt/EBITDA 2.9
Cap/Depr 47.53%
Cap/Sales 3.3%
Interest Coverage 250
Cash Conversion 75.27%
Profit Quality 103.22%
Current Ratio 1.77
Quick Ratio 1.38
Altman-Z 3.55
F-Score8
WACC10.26%
ROIC/WACC0.7
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)1.3%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%0.78%
EPS Next Y3.15%
EPS Next 2Y6.79%
EPS Next 3Y8.38%
EPS Next 5Y8.79%
Revenue 1Y (TTM)0.96%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%0.18%
Revenue Next Year2.15%
Revenue Next 2Y4.1%
Revenue Next 3Y5.02%
Revenue Next 5Y4.89%
EBIT growth 1Y6.86%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year12.01%
EBIT Next 3Y9.78%
EBIT Next 5Y8.38%
FCF growth 1Y19.66%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y5.98%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%